September 8, 2015
NRG-GY001: Amendment 1, Version date: July 30, 2015. Documents are posted on the CTSU website.

RTOG 0631
The registration process has been changed. The calendar base date (start date for radiation treatment) must match the date of registration; when you register the patient use the registration date for the calendar base date.

RTOG 1010 Accrual
Please see the RTOG 1010 webpage for an updated accrual status.

Vision Tree Webinar
The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001 and NRG-HN002. Space is limited so register now and reserve your seat. The next webinar training is scheduled for September 16, 2015.

Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP Members’ Area or the E-mail Distributions page and the CTSU website.

T-VEC Project Team Member Application
Reminder T-VEC Project Team Member Application (PTMA) is due by COB September 18, 2015. Please use the application form on the NRG Oncology website for your submission.

Medidata Rave eLEARNINGS
Beginning October 1, 2015, users of the National Clinical Trials Network instance of Medidata Rave will be required to complete mandatory eLearnings in Rave to ensure continued data entry access. This week we will be inviting all current users to an eLearning study (NRG-ELEARN) in iMedidata to enable the completion of the assigned eLearnings prior to October 1st. If you have any questions, please contact NRG Oncology Support (

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.


Baldini EH, Bosch W, Kane JM 3rd, Abrams RA, Salerno KE, Deville C, Raut CP, Petersen IA, Chen YL, Mullen JT, Millikan KW, Karakousis G, Kendrick ML, DeLaney TF, Wang D. Retroperitoneal Sarcoma (RPS) High Risk Gross Tumor Volume Boost (HR GTV Boost) Contour Delineation Agreement Among NRG Sarcoma Radiation and Surgical Oncologists. Ann Surg Oncol. 2015 Sep;22(9):2846-52. doi: 10.1245/s10434-015-4633-x. Epub 2015 May 28. PubMed PMID: 26018727. Read more

Hong TS, Moughan J, Garofalo MC, Bendell J, Berger AC, Oldenburg NB, Anne PR, Perera F, Lee RJ, Jabbour SK, Nowlan A, DeNittis A, Crane C. NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys. 2015 May 14. pii: S0360-3016(15)00506-4. doi: 10.1016/j.ijrobp.2015.05.005. [Epub ahead of print] PubMed PMID: 26163334. Read more

Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming abstract submission deadlines
American Society of Clinical Oncology (ASCO) GI; Jan 21-23, 2016; San Francisco, CA; meeting abstract submission deadline Sep 22, 2015; meeting abstract submission deadline Sep 8, 2015

American Society of Clinical Oncology (ASCO) GU; Jan 7-9, 2016; San Francisco, CA; meeting abstract submission deadline Sep 9, 2015

Annual Brain Metastases Congress; Oct 2-3, 2015; Marseille, France

Society of Clinical Research (SOCRA); Sep 17-20, 2015; Denver, CO

Society of Gynecologic Oncology (SGO); Mar 19-22, 2016; San Diego, CA; meeting abstract submission deadline Sep 15, 2015

Society of Surgical Oncology (SSO); Mar 2-5, 2016; Boston, MA; meeting abstract submission deadline Sep 14, 2015

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103